Southern Alberta Clinic, University of Calgary, Canada.
AIDS. 2010 Nov 13;24(17):2750-3. doi: 10.1097/QAD.0b013e32833f9e1d.
We determined that for HIV patients presenting with CD4 cell counts less than 350 μl the initial higher costs of care persisted over 5 years. Fifty-nine percent of new patients between 1 April 1998 and 1 April 2003 had CD4 cell counts less than 350 μl. Mean first year total costs ($19 917 $Cdn) were 2.5 times higher than for presentations with CD4 cell counts more than 350 μl ($7840). Total annual costs of care subsequently decreased to $15 663 by year 5, but still remained higher ($8883) than those with CD4 cell counts more than 350 μl despite a median CD4 cell count increase from 134 to 464 μl.
我们发现，对于 CD4 细胞计数低于 350 μl 的 HIV 患者，其在 5 年内的初始治疗费用持续偏高。1998 年 4 月 1 日至 2003 年 4 月 1 日期间，59%的新患者的 CD4 细胞计数低于 350 μl。第一年的平均总费用（19917 加元）是 CD4 细胞计数高于 350 μl 的患者的 2.5 倍（7840 加元）。随后，在第 5 年时，年度总治疗费用降至 15663 加元，但仍高于 CD4 细胞计数高于 350 μl 的患者（8883 加元），尽管 CD4 细胞计数从中位数的 134 μl 增加到 464 μl。
